Preliminary Evaluation of the Safety and Tolerability of SPOT-mRNA01 Subcutaneously Administered in Healthy Subjects
Clinical trial NCT06567119 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06567119
- Sponsor
- SIPO Biotechnology Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2027-01-11
- Primary completion
- 2029-01-12
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.